SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 20 - Sayı: 3

Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy

SİNEM ÖZBAY ÖZYILMAZ
Hamdi PÜŞÜROĞLU
Pages
165–173
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The MTWA was determined as an independent high-risk indicator for HCM Risk-SCD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Micro T-wave alternans (MTWA) has been associated with poor arrhythmic prognosis in various cardiac disorders.
📊
Key Findings & Data:The aim of thisstudy was to assess the relationship between the presence of MTWA and the predicted 5-year risk of sudden cardiac death (HCM Risk-SCD)among patients with hypertrophic cardiomyopathy (HCM).Methods: A total of 117 consecutive HCM patients were included in this prospective observational study.
💡
Conclusion & Impact:The MTWA was determined as an independent high-risk indicator for HCM Risk-SCD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Micro T-wave alternans (MTWA) has been associated with poor arrhythmic prognosis in various cardiac disorders. The aim of thisstudy was to assess the relationship between the presence of MTWA and the predicted 5-year risk of sudden cardiac death (HCM Risk-SCD)among patients with hypertrophic cardiomyopathy (HCM).Methods: A total of 117 consecutive HCM patients were included in this prospective observational study. Patients were divided into two groups,according to the presence [MTWA (+) group (n=44)] or absence [MTWA (−) group (n=73)] of MTWA on ambulatory (Holter) electrocardiography.Results: The risk of HCM Risk-SCD (%), the rate of high-risk patients (HCM Risk-ECG >6%), the requirement for cardiopulmonary resuscitation,and implanted cardioverter defibrillator therapy, the percentage of some clinical, echocardiographic, and Holter findings were all statisticallyhigher in the MTWA (+) group than in the MTWA (−) group (all p 4.9% was identified as an effective cutoff point in the MTWA (+) for HCM.The HCM Risk-SCD value of more than 4.9 yielded a sensitivity of 93.2% and a specificity of 84.5%.Conclusion: The presence of the MTWA on ambulatory electrocardiogram seems to be significantly associated with increasing percentages ofthe predicted HCM Risk-SCD score in patients with HCM. The MTWA was determined as an independent high-risk indicator for HCM Risk-SCD.

🔖

Cite This Article

ÖZYILMAZ, S. Ö., PÜŞÜROĞLU, H. (2018). Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 3, 165–173. https://ajindex.com/articles/365320

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Trivedi A, Knight BP. ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy. Arrhythm Electrophysiol Rev 2016
  2. [CrossRef] Maron MS, Zenovich AG, Casey SA, Link MS, Udelson JE, Aeppli DM, et al. Significance and relationship between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy. Am J Cardiol 2005
  3. [CrossRef] Ozyilmaz S, Akgul O, Uyarel H, Pusuroglu H, Gul M, Satilmisoglu MH, et al. The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy. Rev Port Cardiol 2017
  4. [CrossRef] Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 2008
  5. [CrossRef] Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, et al. The case for myocardial ischemia in Hypertrophic cardiomyopathy. J Am Coll Cardiol 2009
  6. [CrossRef] Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992
  7. [CrossRef] Nienaber CA, Gambhir SS, Mody FV, Ratib O, Huang SC, Phelps ME, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 1993
  8. [CrossRef] Yalın K, Gölcük E, Teker E, Yılmaz R, Dursun M, Bilge AK, et al. No association between scar size and characteristics on T-wave Alternans in post-myocardial infarction patients with relatively preserved ventricular function presented with nonsustained ventricular tachycardia. Anatol J Cardiol 2014
  9. [CrossRef] Özyılmaz S, Akgül Ö, Uyarel H, Pusuroğlu H, Karayakalı M, Gül M, et al. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy. Anatol J Cardiol 2017
  10. [CrossRef] Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005
  11. [CrossRef] Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyp